Showing results (71-80 of 205) with videos related to
Sort By:
Pageof 21
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1991
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic responseR Rosenberg, P Bech, M Mellergård, et al.Psychopharmacology|August 20, 2002
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depressionP Bech, P Tanghøj, H F Andersen, et al.Psychopathology|January 1, 1984
World Health Organization Schedule for Standardized Assessment of Depressive Disorders (WHO/SADD-5). Item combinations and interobserver reliabilityP Bech, A Gjerris, J Andersen, et al.Physiological Reports|December 8, 2017
Reference values of renal tubular function tests are dependent on age and kidney functionAnneke P Bech, Jack F M Wetzels, Tom NijenhuisActa Psychiatrica Scandinavica. Supplementum|January 1, 1991
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatmentR Rosenberg, P Bech, M Mellergård, et al.Acta Psychiatrica Scandinavica|June 22, 2010
Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangleP Bech, P Tanghøj, K Andreasson, et al.European Journal of Clinical Pharmacology|January 1, 1986
Steady-state levels of imipramine and its metabolites: significance of dose-dependent kineticsK Brøsen, L F Gram, R Klysner, et al.Congenital Anomalies|June 30, 2010
Isolation of the left subclavian artery from the pulmonary artery in a patient with CHARGE associationAnneke P Bech, Jeroen op den Akker, Pieter R MatthijsseEuropean Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depressionN Lauge, K Behnke, J Søgaard, et al.Ugeskrift for Laeger|March 27, 1995
[Symptoms of depression in cancer patients undergoing chemotherapy]T Middelboe, L F Ovesen, E L Mortensen, et al.Pageof 21